Chief Scientific Officer (NEO: AWKN | OTCQB: AWKNF) at Awakn Life Sciences - N/A, N/A, gb
Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) is a biotechnology company researching, developing, and delivering revolutionary therapeutics to treat addiction. Awakn's team consists of renowned research experts and world leading chemists, scientists, psychiatrists, and psychologists. Addiction is one of the biggest unmet medical needs of our time, affecting over 20% of the global population and is an industry valued at over $100bn per annum. Awakn is disrupting this underperforming industry by rapidly advancing the next generation of psychedelic drugs and therapies to be used in combination, through preclinical research and clinical stage trials.